Evidence for Novel Pharmacotherapies in Diabetic Kidney Disease
<p id="p1">Chronic kidney disease, defined as abnormal kidney function for more than 3 months, affects roughly 15% of the US, and approximately 40% of people with chronic kidney disease have type 2 diabetes. In the last decade, pharmacotherapies have been approved that may reduce chronic kidney dise...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/1084735 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|